Oct, 2008
Calistoga Pharmaceuticals appoints Carol G. Gallagher, Pharm. D., Chief Executive Officer...read more>

July 10, 2008
Calistoga Pharmaceuticals initiates First Oncology Clinical Trial of Novel Oral PI3K Delta Compound, CAL-101...read more>
Details about the trial can be found at... ClinicalTrials.gov>

March 10, 2008
Calistoga Pharmaceuticals initiates its First Clinical Study of Novel Oral PI3K Delta Compound, CAL-101...read more>

February 14th, 2008
Reuters – New target promises better asthma and allergy drugs...read more>

February 13th, 2008
Calistoga Pharmaceuticals Appoints R. Lee Douglas to
BOD ...read more>

January 3rd, 2008
Calistoga Pharmaceuticals announces completion of its Series A Financing - Investors increased funding by 25% to total $26.2 Million...read more>